Cansortium (XCNQ:TIUM.U) Common Stock : $183.7 Mil (As of Sep. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cansortium Common Stock?

Cansortium's quarterly common stock stayed the same from Mar. 2024 ($183.7 Mil) to Jun. 2024 ($183.7 Mil) and stayed the same from Jun. 2024 ($183.7 Mil) to Sep. 2024 ($183.7 Mil).

Cansortium's annual common stock increased from Dec. 2021 ($180.7 Mil) to Dec. 2022 ($181.0 Mil) and increased from Dec. 2022 ($181.0 Mil) to Dec. 2023 ($183.7 Mil).

Cansortium Common Stock Historical Data

The historical data trend for Cansortium's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cansortium Common Stock Chart

Cansortium Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

149.32

137.84

180.66

180.95

183.69

Cansortium Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Common Stock	Get a 7-Day Free Trial															183.58	183.69	183.69	183.69	183.69

Cansortium Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Cansortium Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cansortium Inc (XCNQ:TIUM.U) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

CNTMF:USA 2WM:Germany

Address

82 North East 26th Street, Unit 110, Miami, FL, USA, 33137

Website

https://getfluent.com

Cansortium Inc is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flowers, pre-rolls, cartridges, and edibles. All of the company's products are marketed under the Fluent brand name. In Pennsylvania, the company's product portfolio is comprised of a variety of third-party branded medical cannabis products.

Cansortium Headlines

No Headlines